Publications by authors named "L J Santin"

Background: The factors influencing sedentary time (ST) of individuals with chronic obstructive pulmonary disease (COPD) have not been thoroughly explored.

Aim: To identify determinant factors of ST in individuals with stable COPD.

Methods: Individuals with COPD had their ST and variables of physical activity (PA) cross-sectionally assessed during seven days with an activity monitor.

View Article and Find Full Text PDF

Tobacco addiction is the primary preventable factor contributing to global mortality, and nicotine is one of the substances with the greatest potential for addiction. With a strong affinity for the α4β2 subtype receptor, cytisine (CYT) functions as a partial agonist of the acetylcholine nicotinic cholinergic receptor. It counteracts the effects of nicotine without causing any withdrawal symptoms.

View Article and Find Full Text PDF

Cocaine-related contextual cues are a recurrent source of craving and relapse. Extinction of cue-driven cocaine seeking remains a clinical challenge, and the search for adjuvants is ongoing. In this regard, combining physical and cognitive training is emerging as a promising strategy that has shown synergistic benefits on brain structure and function, including enhancement of adult hippocampal neurogenesis (AHN), which has been recently linked to reduced maintenance of maladaptive drug seeking.

View Article and Find Full Text PDF

Objective: To develop a natural language processing application capable of automatically identifying benign gallbladder diseases that require surgery, from radiology reports.

Materials And Methods: We developed a text classifier to classify reports as describing benign diseases of the gallbladder that do or do not require surgery. We randomly selected 1,200 reports describing the gallbladder from our database, including different modalities.

View Article and Find Full Text PDF

Introduction: Epithelial ovarian cancer (EOC) is associated with the highest gynecologic cancer mortality. The development of novel, effective combinations of targeted therapeutics remains an unmet medical need. We evaluated the preclinical activity of datopotamab deruxtecan (Dato-Dxd), a novel TROP2 targeting antibody drug conjugate (ADC) in ovarian cancer cell lines and xenografts with variable TROP2 expression.

View Article and Find Full Text PDF